top of page

Mwandishi:

Mhariri:

Imeboershwa:

ULY CLINIC

ULY CLINIC

17 Februari 2026, 14:31:27

Tinea Pedis (Athlete’s Foot)
Tinea Pedis (Athlete’s Foot)

Tinea Pedis (Athlete’s Foot)

Tinea pedis, commonly known as athlete’s foot, is a fungal infection of the feet, predominantly affecting the interdigital spaces, soles, and sometimes the toenails.

  • It is usually caused by dermatophytes, mainly Trichophyton rubrum, T. interdigitale, or Epidermophyton floccosum.

  • The infection is contagious and can spread to other body sites (e.g., hands, groin) via autoinoculation.

  • Predisposing factors include:

    • Excessive sweating (hyperhidrosis)

    • Poor foot hygiene

    • Use of occlusive footwear

    • Communal bathing areas (locker rooms, swimming pools)

    • Immunosuppression


Signs & Symptoms


Acute Form

  • Erythema of interdigital spaces

  • Maceration (softening and whitening of the skin) between toes

  • Painful vesicles or bullae may form

  • Pruritus and burning sensation


Chronic Form

  • Scaling and peeling of the skin, particularly the soles

  • Persistent erythema

  • May spread to other areas of the foot

  • Often less inflammatory than the acute form


Other Features

  • Fissures between toes can serve as portals for secondary bacterial infection

  • Malodor may be present due to fungal and bacterial colonization


Diagnostic Criteria

  • Clinical examination reveals scaling, erythema, and maceration between toes

  • Presence of vesicles or bullae in acute infections

  • Chronic infection characterized by dry, peeling, or thickened skin on soles

  • Typical site: interdigital spaces, lateral borders, and plantar surfaces

  • Laboratory confirmation (if needed):

    • KOH preparation to detect fungal hyphae

    • Fungal culture for species identification


Investigation

  • KOH microscopy: confirms presence of hyphae

  • Fungal culture: identifies causative organism

  • Skin biopsy: rarely required, mainly for atypical or resistant cases

  • Secondary bacterial infection: may require bacterial swab and sensitivity testing


Treatment


Non-Pharmacological Treatment

  • Keep feet dry, particularly between toes

  • Frequent change of socks and footwear

  • Use cotton socks to reduce moisture

  • Separate opposing skin surfaces (e.g., with gauze) to prevent maceration

  • Avoid walking barefoot in communal areas to prevent reinfection


Pharmacological Treatment


Topical Antifungals

  • Clotrimazole 1% cream: apply 12 hourly for 2 weeks

  • Miconazole 2% cream: apply 12 hourly for 2 weeks

  • Terbinafine cream: apply once daily for 7 days


For Secondary Bacterial Infection

  • Gentian violet: apply once daily for 5 days


Systemic Therapy (for severe or refractory cases)

  • Terbinafine (PO) 250 mg daily for 2 weeks

  • Itraconazole (PO) 400 mg daily for 1–2 weeks

Notes:

  • Systemic therapy is generally reserved for widespread, resistant, or recurrent infections

  • Topical therapy remains first-line for localized or mild cases


Prevention

  • Maintain foot hygiene: wash and thoroughly dry feet daily

  • Frequent change of socks and shoes

  • Use breathable footwear and cotton socks

  • Avoid sharing towels, socks, or shoes

  • Use protective footwear in communal areas (showers, pools)

  • Control excessive sweating with powders or antiperspirants if necessary


References

  1. Elewski BE. Tinea pedis: pathophysiology, diagnosis, and management. J Am Acad Dermatol. 1998;39:107–125.

  2. Gupta AK, et al. Management of tinea pedis: a clinical review. Int J Dermatol. 2003;42:783–789.

  3. Hay RJ, et al. Fungal infections of the skin. Lancet. 2014;383:146–155.

  4. Tanzania Ministry of Health. Standard Treatment Guidelines & National Essential Medicines List (STG/NEMLIT). 7th ed. Dodoma: MoH; 2023.


Imeandikwa;

3 Novemba 2020, 10:35:11

bottom of page